These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 536275)

  • 1. Combination therapy with radiation and mitomycin C: preliminary results with EMT6 tumor cells in vitro and in vivo.
    Rockwell S; Kennedy KA
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1673-6. PubMed ID: 536275
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
    Rockwell S
    J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C.
    Keyes SR; Heimbrook DC; Fracasso PM; Rockwell S; Sligar SG; Sartorelli AC
    Adv Enzyme Regul; 1985; 23():291-307. PubMed ID: 3934922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of BMS-181174 and radiation: studies with EMT6 cells in vitro and in solid tumors.
    Rockwell S; Kelley M
    Radiother Oncol; 1996 Apr; 39(1):65-71. PubMed ID: 8735495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivo.
    Rockwell S; Keyes SR; Loomis R; Kelley M; Vyas DM; Wong H; Doyle TW; Sartorelli AC
    Cancer Commun; 1991 Jun; 3(6):191-8. PubMed ID: 2049227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):127-33. PubMed ID: 8270433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.
    Pritsos CA; Sartorelli AC
    Cancer Res; 1986 Jul; 46(7):3528-32. PubMed ID: 3011250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 8. Effect of mitomycin C-treated active specific immunotherapy].
    Imanaka K; Gose K; Ichiyanagi A; Ashida C; Hamada F; Hashimura T; Takimoto S; Murakami M; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):940-5. PubMed ID: 6413626
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):213-6. PubMed ID: 2578093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Aug; 45(8):3642-5. PubMed ID: 3926306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies of porfiromycin as an adjunct to radiotherapy.
    Rockwell S; Keyes SR; Sartorelli AC
    Radiat Res; 1988 Oct; 116(1):100-13. PubMed ID: 3186923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicities of mitomycin C and x rays to aerobic and hypoxic cells in vitro.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1035-9. PubMed ID: 6809713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
    Rockwell S; Schulz RJ
    Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mitomycin antibiotics in the chemotherapy of solid tumors.
    Sartorelli AC
    Biochem Pharmacol; 1986 Jan; 35(1):67-9. PubMed ID: 2416320
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells.
    Kennedy KA; Rockwell S; Sartorelli AC
    Cancer Res; 1980 Jul; 40(7):2356-60. PubMed ID: 7388797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glutathione and ethylxanthate on mitomycin C activation by isolated rat hepatic or EMT6 mouse mammary tumor nuclei.
    Kennedy KA; Mimnaugh EG; Trush MA; Sinha BK
    Cancer Res; 1985 Sep; 45(9):4071-6. PubMed ID: 2411396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the cytotoxicity of porfiromycin by dicoumarol in vitro and in vivo.
    Rockwell S; Keyes SR; Sartorelli AC
    Anticancer Res; 1989; 9(4):817-20. PubMed ID: 2479329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.